FOSRENOL Side Effects

6701851-0 | Myocardial Infarction
on Apr 21, 2010 Female patient from UNITED STATES , weighting 50.93 lb, was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Fosrenol dosage: .

6701842-X | Foreign Body, Oesophageal Haemorrhage, Product Quality Issue, Product Size Issue
Patient was taking Fosrenol (View Usage). Patient had the following side effects: foreign body, oesophageal haemorrhage, product quality issue, product size issue on Apr 21, 2010 from UNITED STATES Additional patient health information: Female patient , 89 years of age, weighting 100.3 lb, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1 X/day;qd, Oral. Patient was hospitalized.

6700170-6 | Fall, Melaena, Pelvic Fracture, Rectal Ulcer, X-ray Gastrointestinal Tract Abnormal
Adverse event was reported on Apr 15, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: 2250 Mg, Oral) was diagnosed with hyperphosphataemia, atrial fibrillation (What is atrial fibrillation?) and. Location: JAPAN , 80 years of age, After Fosrenol was administered, patient had the following side effects: fall (What is fall?), melaena, pelvic fracture, rectal ulcer, x-ray gastrointestinal tract abnormal. During the same period patient was treated with WARFARIN SODIUM (Oral) (View Warfarin Sodium Review and Warfarin Sodium Label ), PHOSBLOCK (SEVELAMER HYDROCHLORIDE) (View Phosblock (sevelamer Hydrochloride) Review and Phosblock (sevelamer Hydrochloride) Label ), PERSANTIN (View Persantin Review and Persantin Label ), DOPS (DROXIDOPA) (View Dops (droxidopa) Review and Dops (droxidopa) Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SORBITOL (SORBITOL) (View Sorbitol (sorbitol) Review and Sorbitol (sorbitol) Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), SENNOSIDE A+B CALCIUM (SENNOSIDE A+B CALCIUM) (View Sennoside A+b Calcium (sennoside A+b Calcium) Review and Sennoside A+b Calcium (sennoside A+b Calcium) Label ). Patient was hospitalized.

6699472-1 | Treatment Noncompliance
on Apr 21, 2010 Female patient from UNITED STATES , 83 years of age, was diagnosed with renal failure chronic and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: treatment noncompliance. Fosrenol dosage: 1000 Mg, 4x/day:qid, Oral.


6699469-1 | Pneumonia, Pyrexia
on Apr 21, 2010 Female patient from UNITED STATES , 60 years of age, weighting 155.0 lb, was diagnosed with hyperphosphataemia, renal failure chronic and was treated with Fosrenol (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), pyrexia. Fosrenol dosage: 1000 Mg, 1xlday:qd With Biggest Meal, Oral. During the same period patient was treated with ZETIA (EZETIMIBE) TABLET (View Zetia (ezetimibe) Tablet Review and Zetia (ezetimibe) Tablet Label ), LIPITOR (View Lipitor Review and Lipitor Label ), PRILOSEC /00661203/ (OMEPRAZOLE MAGNESIUM) CAPSULE (View Prilosec /00661203/ (omeprazole Magnesium) Capsule Review and Prilosec /00661203/ (omeprazole Magnesium) Capsule Label ), ZOLOFT /01011402/ (SERTRALINE HYDROCHLORIDE) TABLET (View Zoloft /01011402/ (sertraline Hydrochloride) Tablet Review and Zoloft /01011402/ (sertraline Hydrochloride) Tablet Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ). Patient was hospitalized.

6697768-0 | Duodenal Ulcer, Shunt Aneurysm
Patient was taking Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: duodenal ulcer, shunt aneurysm on Apr 20, 2010 from JAPAN Additional patient health information: Female patient , 69 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 250 Mg, Oral. During the same period patient was treated with CALTAN (CALCIUM CARBONATE) (View Caltan (calcium Carbonate) Review and Caltan (calcium Carbonate) Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), SHAKUYAKUKANZOUTOU (HERVAL EXTRACT NOS) (View Shakuyakukanzoutou (herval Extract Nos) Review and Shakuyakukanzoutou (herval Extract Nos) Label ), PROTECTION (LAFUTIDINE) (View Protection (lafutidine) Review and Protection (lafutidine) Label ). Patient was hospitalized.

6697595-4 | Blood Phosphorus Increased, Cough, Dyspnoea, Heart Rate Irregular, Hypophagia, Treatment Noncompliance
Adverse event was reported on Apr 19, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: 1000 Mg With Every Meal, Oral) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , 74 years of age, weighting 162.0 lb, Patient experienced the following unwanted or unexpected effects: blood phosphorus increased, cough, dyspnoea, heart rate irregular, hypophagia, treatment noncompliance. During the same period patient was treated with RENAVIT (ASCORBIC ACID, BIOTIN, CALCIUM PANTOTHENATE, FOLIC ACID, NICO (View Renavit (ascorbic Acid, Biotin, Calcium Pantothenate, Folic Acid, Nico Review and Renavit (ascorbic Acid, Biotin, Calcium Pantothenate, Folic Acid, Nico Label ), PROPRANOLOL /00030001/ (PROPRANOLOL) TABLET (View Propranolol /00030001/ (propranolol) Tablet Review and Propranolol /00030001/ (propranolol) Tablet Label ), ZETIA (EZETIMIBE) TABLET (View Zetia (ezetimibe) Tablet Review and Zetia (ezetimibe) Tablet Label ). Patient was hospitalized.

6696880-X | Abdominal Distension, Constipation, Dialysis, Discomfort
on Apr 14, 2010 Male patient from JAPAN , 54 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: abdominal distension, constipation (What is constipation?), dialysis (What is dialysis?), discomfort. Fosrenol dosage: 750 Mg Total Daily Dose, Oral.

6694202-1 | Arrhythmia, Dysphagia, Oropharyngeal Pain, Shunt Occlusion
on Apr 15, 2010 Female patient from UNITED STATES , 85 years of age, weighting 162.9 lb, was diagnosed with hyperphosphataemia, renal failure chronic and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), dysphagia, oropharyngeal pain, shunt occlusion. Fosrenol dosage: 1000 Mg, 1x/day:qd, Oral. During the same period patient was treated with NEPHROCAPS (View Nephrocaps Review and Nephrocaps Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), BOTIN (View Botin Review and Botin Label ), CYNOCOBALAMIN (View Cynocobalamin Review and Cynocobalamin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), NICOTINAMIDE (View Nicotinamide Review and Nicotinamide Label ), PANTOTHENIC ACID, PYRIDOXINE HYDROCHLORIDE, RIBOFLAVIN, THIAMINE HYDRO (View Pantothenic Acid, Pyridoxine Hydrochloride, Riboflavin, Thiamine Hydro Review and Pantothenic Acid, Pyridoxine Hydrochloride, Riboflavin, Thiamine Hydro Label ). Patient was hospitalized.

6694201-X | Condition Aggravated, Heart Valve Incompetence
Patient was taking Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, heart valve incompetence on Apr 13, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, weighting 160.1 lb, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg, 3x/day: Tid, Oral. Patient was hospitalized.

6692624-6 |
Adverse event was reported on Apr 14, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: Oral) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , 80 years of age, .

6691543-9 | Foreign Body Aspiration, X-ray Abnormal
on Apr 14, 2010 Male patient from JAPAN , 61 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: foreign body aspiration, x-ray abnormal. Fosrenol dosage: 750 Mg Total Daily Dose, Oral; 750 Mg Total Daily Dose, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6689335-X | Angina Pectoris, Shunt Malfunction
on Apr 12, 2010 Male patient from JAPAN , 71 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, shunt malfunction. Fosrenol dosage: 750 Mg, Oral. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), TAPIZOL (LANSOPRAZOLE) (View Tapizol (lansoprazole) Review and Tapizol (lansoprazole) Label ), ARICEPT /1318901/ (DONEPEZIL HYDROCHLORIDE) (View Aricept /1318901/ (donepezil Hydrochloride) Review and Aricept /1318901/ (donepezil Hydrochloride) Label ), DORNER (BERAPROST SODIUM) (View Dorner (beraprost Sodium) Review and Dorner (beraprost Sodium) Label ), ANPLAG (SARPOGRELATE HYDROCHLORIDE) (View Anplag (sarpogrelate Hydrochloride) Review and Anplag (sarpogrelate Hydrochloride) Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), HALCION (View Halcion Review and Halcion Label ), YOKUKAN SAN (HERBAL EXTRACT NOS) (View Yokukan-san (herbal Extract Nos) Review and Yokukan-san (herbal Extract Nos) Label ).

6689334-8 | Gastroenteritis
Patient was taking Fosrenol (View Usage). Patient had the following side effects: gastroenteritis (What is gastroenteritis?) on Apr 13, 2010 from JAPAN Additional patient health information: Male patient , 47 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: See Image. During the same period patient was treated with TANKARU (CALCIUM CARBONATE) (View Tankaru (calcium Carbonate) Review and Tankaru (calcium Carbonate) Label ), ALFAROL (ALFACALCIDOL) (View Alfarol (alfacalcidol) Review and Alfarol (alfacalcidol) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LASIX (View Lasix Review and Lasix Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), FLUITRAN (TRICHLORMETHIAZIDE) (View Fluitran (trichlormethiazide) Review and Fluitran (trichlormethiazide) Label ). Patient was hospitalized.

6687623-4 | Anaemia, Cardiovascular Disorder, Gastritis Erosive, Haemodialysis, Immune System Disorder, Malaise, Staphylococcal Infection, Upper Gastrointestinal Haemorrhage
Adverse event was reported on Apr 09, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: 750 Mg Total Daily Dose, Oral) was diagnosed with hyperphosphataemia, myocardial ischaemia, cerebral infarction and. Location: JAPAN , 69 years of age, After Fosrenol was administered, patient had the following side effects: anaemia, cardiovascular disorder, gastritis erosive, haemodialysis, immune system disorder, malaise, staphylococcal infection (What is staphylococcal infection?), upper gastrointestinal haemorrhage. During the same period patient was treated with PLAVIX (75 Mg Total Daily Dose, Oral) (View Plavix Review and Plavix Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ).

6687620-9 | Large Intestine Perforation, Peritonitis, X-ray Gastrointestinal Tract Abnormal
on Apr 09, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: large intestine perforation, peritonitis, x-ray gastrointestinal tract abnormal. Fosrenol dosage: Oral. Patient was hospitalized.

6687261-3 |
on Apr 13, 2010 Male patient from UNITED STATES , 46 years of age, weighting 78.48 lb, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). . Fosrenol dosage: 1500 Mg With Meals, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), COREG (View Coreg Review and Coreg Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), XANAX (View Xanax Review and Xanax Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), LANTUS (View Lantus Review and Lantus Label ).

6683535-0 | Calcinosis, Diverticulum, Ileus, X-ray Gastrointestinal Tract Abnormal
Patient was taking Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: calcinosis, diverticulum, ileus, x-ray gastrointestinal tract abnormal on Apr 08, 2010 from JAPAN Additional patient health information: Male patient , 36 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 750 Mg Total Dail Dose, Oral. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), NESP (DARBEPOETIN ALFA) (View Nesp (darbepoetin Alfa) Review and Nesp (darbepoetin Alfa) Label ). Patient was hospitalized.

6682899-1 | Fall
Adverse event was reported on Apr 06, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: 1000 Mg With Meals, Oral) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , 59 years of age, weighting 340.0 lb, Patient experienced the following unwanted or unexpected effects: fall (What is fall?). During the same period patient was treated with ZEMPLAR (View Zemplar Review and Zemplar Label ), EPOETIN (EPOETIN ALFA) (View Epoetin (epoetin Alfa) Review and Epoetin (epoetin Alfa) Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6682740-7 | Blood Phosphorus Decreased, Surgery
on Apr 09, 2010 Female patient from UNITED STATES , 60 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: blood phosphorus decreased, surgery (What is surgery?). Fosrenol dosage: Oral.

6682739-0 | Blood Calcium Decreased, Diarrhoea, Heart Rate Increased, Procedural Hypotension
on Mar 24, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: blood calcium decreased, diarrhoea, heart rate increased, procedural hypotension. Fosrenol dosage: 2000 Mg Twice Daily And 1000 Mg Three Times Daily, Oral. During the same period patient was treated with CARBIDOPA AND LEVODOPA (CARBIDOPA, LEVODOPA) TABLET (View Carbidopa And Levodopa (carbidopa, Levodopa) Tablet Review and Carbidopa And Levodopa (carbidopa, Levodopa) Tablet Label ), CORVALOL (BROMISOVAL, PHENOBARBITAL SODIUM) TABLET (View Corvalol (bromisoval, Phenobarbital Sodium) Tablet Review and Corvalol (bromisoval, Phenobarbital Sodium) Tablet Label ).

6681107-5 | Anaemia, Blood Urea Increased, Cerebral Infarction, Endocarditis Bacterial, Gastritis Erosive, Haemodialysis, Immune System Disorder, Inflammation, Malaise
Patient was taking Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood urea increased, cerebral infarction, endocarditis bacterial, gastritis erosive, haemodialysis, immune system disorder, inflammation, malaise on Apr 02, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with hyperphosphataemia, myocardial ischaemia, cerebral infarction and. Fosrenol dosage: 750 Mg Total Daily Dose, Oral. During the same period patient was treated with PLAVIX (75 Mg Total Daily Dose, Oral) (View Plavix Review and Plavix Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), SIGMART (NICORANDIL) (View Sigmart (nicorandil) Review and Sigmart (nicorandil) Label ).

6681100-2 | Ileus
Adverse event was reported on Apr 02, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: Oral) was diagnosed with hyperphosphataemia and. Location: JAPAN , 68 years of age, Patient had the following side effects: ileus. During the same period patient was treated with CORINAE L (NIFEDIPINE) (View Corinae L (nifedipine) Review and Corinae L (nifedipine) Label ), DEPAS (ETIZOLAM) (View Depas (etizolam) Review and Depas (etizolam) Label ), VEGETAMIN B (View Vegetamin B Review and Vegetamin B Label ), FERROMIA (FERROUS CITRATE) (View Ferromia (ferrous Citrate) Review and Ferromia (ferrous Citrate) Label ), COMESGEN (MECOBALAMIN) (View Comesgen (mecobalamin) Review and Comesgen (mecobalamin) Label ), PAXIL (View Paxil Review and Paxil Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), PLETAL (View Pletal Review and Pletal Label ).

6680113-4 | Dermatitis Exfoliative, Oedema Peripheral
on Apr 01, 2010 Male patient from ITALY , 74 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: dermatitis exfoliative, oedema peripheral. Fosrenol dosage: 500 Mg, 1x1day:qd, Oral . During the same period patient was treated with INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ).

6679989-6 | Respiratory Arrest
on Apr 06, 2010 Female patient from UNITED STATES , 70 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory arrest. Fosrenol dosage: Oral. Patient was hospitalized.

6679897-0 | Pneumonia
Patient was taking Fosrenol (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?) on Apr 06, 2010 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 140.0 lb, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg Three Times Daily With Meals And 500 Mg Twice Daily With Snacks, Oral. During the same period patient was treated with HYDRAZINE (HYDRAZINE) (View Hydrazine (hydrazine) Review and Hydrazine (hydrazine) Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), RENVELA (View Renvela Review and Renvela Label ), REQUIP (View Requip Review and Requip Label ), BUSPAR (View Buspar Review and Buspar Label ), FEXERIL (/00428402/) (CYCLOVENZAPRINE HYDROCHLORIDE) (View Fexeril (/00428402/) (cyclovenzaprine Hydrochloride) Review and Fexeril (/00428402/) (cyclovenzaprine Hydrochloride) Label ), AMBIEN (View Ambien Review and Ambien Label ), PROAMATINE (View Proamatine Review and Proamatine Label ). Patient was hospitalized.

6675124-9 | Dermatitis Allergic, Granulocyte Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Apr 01, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: 750 Mg Total Daily Dose, Oral) was diagnosed with hyperphosphataemia, subdiaphragmatic abscess and. Location: JAPAN , 49 years of age, After Fosrenol was administered, patient had the following side effects: dermatitis allergic, granulocyte count decreased, white blood cell count decreased. During the same period patient was treated with MEROPENEM (Intravenous) (View Meropenem Review and Meropenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PAXIL (View Paxil Review and Paxil Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RENAGEL (View Renagel Review and Renagel Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CLARITIN /00413701/ (GLICLAZIDE) (View Claritin /00413701/ (gliclazide) Review and Claritin /00413701/ (gliclazide) Label ). Patient was hospitalized.

6675123-7 | Ileus
on Apr 01, 2010 Male patient from JAPAN , 36 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: ileus. Fosrenol dosage: 750 Mg Total Daily Dose, Oral. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), CALCIUM CARBONATE (CACLIUM CARBONATE) (View Calcium Carbonate (caclium Carbonate) Review and Calcium Carbonate (caclium Carbonate) Label ), NESP (DARBEPOETIN ALFA) (View Nesp (darbepoetin Alfa) Review and Nesp (darbepoetin Alfa) Label ). Patient was hospitalized.

6673989-8 |
on Mar 31, 2010 Male patient from UNITED STATES , 81 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). . Fosrenol dosage: 1000 Mg, 3x/day;tid, Oral.

6673988-6 | Abdominal Pain, Cholecystectomy, Diarrhoea, Dyspnoea, Dyspnoea Exertional, Gastric Varices, Helicobacter Infection, Hepatic Failure
Patient was taking Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cholecystectomy, diarrhoea, dyspnoea, dyspnoea exertional, gastric varices, helicobacter infection, hepatic failure on Apr 01, 2010 from UNITED STATES Additional patient health information: Male patient , 65 years of age, weighting 172.0 lb, was diagnosed with thrombosis prophylaxis and. Fosrenol dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), RENAGEL (1600 Mg, Every Day) (View Renagel Review and Renagel Label ), ALBUTEROL /00139501/ (SALBUTAMOL) (View Albuterol /00139501/ (salbutamol) Review and Albuterol /00139501/ (salbutamol) Label ), ALPHAGAN /0131101/ (BRIMONIDINE) (View Alphagan /0131101/ (brimonidine) Review and Alphagan /0131101/ (brimonidine) Label ), AMBIEN (ZOLPIDEM TRATRATE) (View Ambien (zolpidem Tratrate) Review and Ambien (zolpidem Tratrate) Label ), VITAMIN B COMPLEX /00003501/ (CALCIUM PANTOTHENATE, NICOTINAMIDE, PYRI (View Vitamin B Complex /00003501/ (calcium Pantothenate, Nicotinamide, Pyri Review and Vitamin B Complex /00003501/ (calcium Pantothenate, Nicotinamide, Pyri Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.

6673048-4 | Fluid Retention
Adverse event was reported on Mar 30, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: Oral) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , 58 years of age, Patient experienced the following unwanted or unexpected effects: fluid retention. Patient was hospitalized.

6669126-6 | Dermatitis Allergic, Eosinophil Count Increased, Granulocyte Count Decreased, Urticaria, White Blood Cell Count Decreased
on Mar 25, 2010 Male patient from JAPAN , 49 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: dermatitis allergic, eosinophil count increased, granulocyte count decreased, urticaria, white blood cell count decreased. Fosrenol dosage: Oral. During the same period patient was treated with MEROPENEM (Intravenous) (View Meropenem Review and Meropenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

6669039-X | Cellulitis
on Mar 30, 2010 Male patient from UNITED STATES , 73 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: cellulitis (What is cellulitis?). Fosrenol dosage: 1000 Mg, With Meals Half With Snacks Bid, Oral. Patient was hospitalized.

6669038-8 | Cardiovascular Disorder
Patient was taking Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: cardiovascular disorder on Mar 30, 2010 from UNITED STATES Additional patient health information: Female patient , 51 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: Mg, Oral. During the same period patient was treated with MORPHINE (Mg,) (View Morphine Review and Morphine Label ). Patient was hospitalized.

6668497-4 | Blood Urea Decreased, Blood Urea Increased, Colonic Stenosis, Haematocrit Decreased, Haemoglobin Decreased, Ileus, Large Intestinal Stricture, Melaena
Adverse event was reported on Mar 24, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: 750 Mg Daily, Oral 750 Mg Daily, Oral) was diagnosed with hyperphosphataemia and. Location: JAPAN , 70 years of age, Patient had the following side effects: blood urea decreased, blood urea increased, colonic stenosis, haematocrit decreased, haemoglobin decreased, ileus, large intestinal stricture, melaena. During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), ULTIVA (View Ultiva Review and Ultiva Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), ANAPEINE (ROPIVACAINE HYDROCHLORIDE) (View Anapeine (ropivacaine Hydrochloride) Review and Anapeine (ropivacaine Hydrochloride) Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), JUVELA N (TOCOPHERYL NICOTINATE) (View Juvela N (tocopheryl Nicotinate) Review and Juvela N (tocopheryl Nicotinate) Label ).

6668396-8 | Colonic Stenosis, Ileus, Large Intestinal Stricture, Small Intestinal Perforation
on Mar 24, 2010 Female patient from JAPAN , 70 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: colonic stenosis, ileus, large intestinal stricture, small intestinal perforation. Fosrenol dosage: 750 Mg Daily, Oral 750 Mg Daily, Oral. During the same period patient was treated with DIPRIVAN (View Diprivan Review and Diprivan Label ), ROCURONIUM BROMIDE (ROCURNIUM BROMIDE) (View Rocuronium Bromide (rocurnium Bromide) Review and Rocuronium Bromide (rocurnium Bromide) Label ), ULTIVA (View Ultiva Review and Ultiva Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), ANAPEINE (ROPIVACAINE HYRDOCHLORIDE) (View Anapeine (ropivacaine Hyrdochloride) Review and Anapeine (ropivacaine Hyrdochloride) Label ), XYLOCAINE (View Xylocaine Review and Xylocaine Label ), JUVELA N (TOCOPHERYL NICOTINATE) (View Juvela N (tocopheryl Nicotinate) Review and Juvela N (tocopheryl Nicotinate) Label ).

6667684-9 | Knee Operation
on Mar 29, 2010 Male patient from UNITED STATES , 73 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: knee operation. Fosrenol dosage: 1000 Mg. Tablet After Meals, Oral. During the same period patient was treated with RENVELA (View Renvela Review and Renvela Label ). Patient was hospitalized.

6667683-7 | Device Malfunction, Myocardial Infarction
Patient was taking Fosrenol (View Usage). Patient had the following side effects: device malfunction, myocardial infarction on Mar 25, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, weighting 168.9 lb, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 1000 Mg, After Every Meal, Oral. Patient was hospitalized.

6667676-X | Coagulopathy
Adverse event was reported on Mar 29, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: Oral) . Location: UNITED STATES , 80 years of age, After Fosrenol was administered, patient had the following side effects: coagulopathy. Patient was hospitalized.

6666804-X | Hypercalcaemia, Meniscus Lesion, Osteonecrosis, Stress Fracture
on Mar 23, 2010 Male patient from FINLAND , 65 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: hypercalcaemia, meniscus lesion, osteonecrosis (What is osteonecrosis?), stress fracture. Fosrenol dosage: Oral. During the same period patient was treated with CINACALCET HYDROCHLORIDE (30 Mg) (View Cinacalcet Hydrochloride Review and Cinacalcet Hydrochloride Label ), RENAGEL (800 Mg, 8x/day) (View Renagel Review and Renagel Label ), PARICALCITOL (PARICALCITOL) (View Paricalcitol (paricalcitol) Review and Paricalcitol (paricalcitol) Label ), ARANESP (View Aranesp Review and Aranesp Label ), AMARYL (View Amaryl Review and Amaryl Label ).

6666430-2 | Dysphonia, Dyspnoea, Hypophagia
on Mar 25, 2010 Female patient from UNITED STATES , 49 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: dysphonia, dyspnoea, hypophagia. Fosrenol dosage: 1000 Mg, Tablet With Meals, Oral. Patient was hospitalized.

6666426-0 | Blood Pressure Decreased, Hypovolaemia
Patient was taking Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: blood pressure decreased, hypovolaemia on Mar 26, 2010 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 500 Mg, Other (with Meals), Oral. Patient was hospitalized.

6666143-7 | Adverse Event, Blood Phosphorus Decreased, Blood Phosphorus Increased, Renal Failure, Vascular Graft Complication
Adverse event was reported on Mar 23, 2010 by a Male patient taking Fosrenol (View Usage) (Dosage: 250 Mg, 2x/day: Bid, Breakfast And Lunch, Oral; See Image) was diagnosed with hyperphosphataemia, renal failure and. Location: UNITED STATES , 76 years of age, weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: adverse event, blood phosphorus decreased, blood phosphorus increased, renal failure, vascular graft complication. Patient was hospitalized.

6666141-3 | Cough, Fluid Overload
on Mar 22, 2010 Male patient from UNITED STATES , 58 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). Patient had the following side effects: cough, fluid overload. Fosrenol dosage: 1000 Mg With Each Meal Daily, Oral. Patient was hospitalized.

6664732-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Erythema, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Liver Disorder, Pruritus, Rash
on Mar 25, 2010 Male patient from JAPAN , 59 years of age, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, erythema, gamma-glutamyltransferase increased, hepatic function abnormal, liver disorder, pruritus, rash (What is rash?). Fosrenol dosage: Oral. During the same period patient was treated with FIRSTCIN (CEFOZOPRAN HYDROCHLORIDE) (View Firstcin (cefozopran Hydrochloride) Review and Firstcin (cefozopran Hydrochloride) Label ), AMLODINE (AMLODIPINE) (View Amlodine (amlodipine) Review and Amlodine (amlodipine) Label ), LASIX (View Lasix Review and Lasix Label ), CALCIUM LACTATE (CALCIUM LACTATE) (View Calcium Lactate (calcium Lactate) Review and Calcium Lactate (calcium Lactate) Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), CEFOZOPRAN HYDROCHLORIDE (CEFOZOPRAN HYDROCHLORIDE) (View Cefozopran Hydrochloride (cefozopran Hydrochloride) Review and Cefozopran Hydrochloride (cefozopran Hydrochloride) Label ).

6664731-5 | Acute Myocardial Infarction, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Hepatic Function Abnormal, Pyrexia
Patient was taking Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, hepatic function abnormal, pyrexia on Mar 24, 2010 from JAPAN Additional patient health information: Female patient , 56 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: . During the same period patient was treated with MAXIPIME (View Maxipime Review and Maxipime Label ), CALTAN (CALCIUM CARBONATE) (View Caltan (calcium Carbonate) Review and Caltan (calcium Carbonate) Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), MICARDIS (View Micardis Review and Micardis Label ), PROTECADINE (LAFUTIDINE) (View Protecadine (lafutidine) Review and Protecadine (lafutidine) Label ), YODEL (SENNA ALEXANDRINA) (View Yodel (senna Alexandrina) Review and Yodel (senna Alexandrina) Label ), VASOLAN /00014302/ (VERAPAMIL HYDROCHLORIDE) (View Vasolan /00014302/ (verapamil Hydrochloride) Review and Vasolan /00014302/ (verapamil Hydrochloride) Label ). Patient was hospitalized.

6656815-2 | Asthenia, Cough
Adverse event was reported on Mar 17, 2010 by a Female patient taking Fosrenol (View Usage) (Dosage: Mg, 3x/day:tid, Oral) was diagnosed with hyperphosphataemia and. Location: UNITED STATES , 80 years of age, Patient had the following side effects: asthenia, cough. Patient was hospitalized.

6656814-0 | Cardiac Failure Congestive
on Mar 17, 2010 Female patient from UNITED STATES , 64 years of age, weighting 140.9 lb, was diagnosed with hyperphosphataemia and was treated with Fosrenol (View Usage). After Fosrenol was administered, patient had the following side effects: cardiac failure congestive. Fosrenol dosage: Mg, 3x/day:tid, Oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), RENAGEL /01459901/ (SEVELAMER) TABLET (View Renagel /01459901/ (sevelamer) Tablet Review and Renagel /01459901/ (sevelamer) Tablet Label ), DIOVAN (View Diovan Review and Diovan Label ), GLUCOPHAGE /00082701/ (METFORMIN) TABLET (View Glucophage /00082701/ (metformin) Tablet Review and Glucophage /00082701/ (metformin) Tablet Label ). Patient was hospitalized.

6656812-7 | Diarrhoea, Headache, Hypotension, Pneumonia
on Mar 16, 2010 Male patient from UNITED STATES , 51 years of age, weighting 248.9 lb, was diagnosed with hyperphosphataemia, renal failure and was treated with Fosrenol (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, headache (What is headache?), hypotension, pneumonia (What is pneumonia?). Fosrenol dosage: Mg, With Meals, Oral. Patient was hospitalized.

6656505-6 | Back Disorder, Nausea, Syncope
Patient was taking Fosrenol (View Usage). Patient had the following side effects: back disorder, nausea (What is nausea?), syncope on Mar 19, 2010 from UNITED STATES Additional patient health information: Male patient , 49 years of age, was diagnosed with hyperphosphataemia and. Fosrenol dosage: 2000 Mg With Meals + 1000mg With Snacks, Oral. Patient was hospitalized.